SynAct Pharma AB · OMXSTO:SYNACT

Boesen Biotech ApS bought 5,450 SynAct Pharma AB shares (MAR article 19 notification)

Traded Mar 3, 2026 · Filed Mar 6, 2026 · Read by 6ix Oct 14, 2026

On Mar 3, 2026, Boesen Biotech ApS (Closely associated with Thomas Boesen (Other member of the company's administrative, management or supervisory body)) bought 5,450 SynAct Pharma AB shares at an average SEK 17.91 for SEK 97,610. Filed Mar 6, 2026 (MAR article 19 notification).

Bought
5,450 shares
Price
SEK 17.91 average (SEK 17.90 to SEK 17.92)
Value
SEK 97,610
Role
Closely associated with Thomas Boesen (Other member of the company's administrative, management or supervisory body)

The register entry

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 3, 2026SynAct Pharma ABBuy2,700SEK 17.90Indirect
Mar 3, 2026SynAct Pharma ABBuy2,750SEK 17.92Indirect

Source

View original at Finansinspektionen

Related